phosphoserine has been researched along with Huntington Disease in 5 studies
Phosphoserine: The phosphoric acid ester of serine.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martín-Flores, N | 1 |
| Pérez-Sisqués, L | 1 |
| Creus-Muncunill, J | 1 |
| Masana, M | 1 |
| Ginés, S | 2 |
| Alberch, J | 1 |
| Pérez-Navarro, E | 1 |
| Malagelada, C | 1 |
| Daldin, M | 1 |
| Fodale, V | 1 |
| Cariulo, C | 1 |
| Azzollini, L | 1 |
| Verani, M | 1 |
| Martufi, P | 1 |
| Spiezia, MC | 1 |
| Deguire, SM | 1 |
| Cherubini, M | 1 |
| Macdonald, D | 1 |
| Weiss, A | 1 |
| Bresciani, A | 1 |
| Vonsattel, JG | 1 |
| Petricca, L | 1 |
| Marsh, JL | 1 |
| Santimone, I | 1 |
| Marano, M | 1 |
| Lashuel, HA | 1 |
| Squitieri, F | 1 |
| Caricasole, A | 1 |
| Roe, AJ | 1 |
| Qi, X | 1 |
| Pineda, JR | 1 |
| Pardo, R | 1 |
| Zala, D | 1 |
| Yu, H | 1 |
| Humbert, S | 2 |
| Saudou, F | 2 |
1 review available for phosphoserine and Huntington Disease
| Article | Year |
|---|---|
[Huntington's disease: intracellular signaling pathways and neuronal death].
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Axonal Transport; Brain-Derived Neurotrophic Fact | 2005 |
4 other studies available for phosphoserine and Huntington Disease
| Article | Year |
|---|---|
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cells, Cultured; Cerebral Cortex; Corpus Striatum; De | 2020 |
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
Topics: Animals; Brain; Disease Models, Animal; Drosophila; Exons; Fibroblasts; HEK293 Cells; Humans; Huntin | 2017 |
Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
Topics: Animals; Butadienes; Corpus Striatum; Dynamins; GTP Phosphohydrolases; Huntington Disease; Membrane | 2018 |
Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.
Topics: Animals; Biological Transport; Brain-Derived Neurotrophic Factor; Calcineurin; Calcineurin Inhibitor | 2009 |